RAYMOND JAMES & ASSOCIATES - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 116 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q1 2022$951,000
-41.0%
50,288
+9.5%
0.00%0.0%
Q4 2021$1,611,000
-1.1%
45,937
+3.2%
0.00%0.0%
Q3 2021$1,629,000
+2.5%
44,508
+9.9%
0.00%0.0%
Q2 2021$1,590,000
+292.6%
40,487
+182.7%
0.00%
Q1 2021$405,000
-2.9%
14,324
+9.9%
0.00%
Q4 2020$417,000
+6.4%
13,031
+7.4%
0.00%
Q3 2020$392,000
+29.8%
12,138
+10.9%
0.00%
Q2 2020$302,00010,9470.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q2 2022
NameSharesValueWeighting ↓
INDUS CAPITAL PARTNERS, LLC 1,304,603$15,525,0001.47%
Prudence Asset Management Ltd 37,148$442,0000.33%
Prince Street Capital Management LLC 87,700$1,044,0000.19%
PRUDENTIAL PLC 1,306,437$15,599,0000.06%
Folger Hill Asset Management LP 60,950$725,0000.04%
SCHRODER INVESTMENT MANAGEMENT GROUP 624,543$7,457,0000.01%
Pine River Capital Management L.P. 28,641$341,0000.01%
Sumitomo Mitsui Trust Holdings, Inc. 209,420$2,492,0000.00%
Allianz Asset Management GmbH 299,200$3,560,0000.00%
Baillie Gifford 152,926$1,826,0000.00%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders